Key result
Permanent explantation of ICDs without replacement in selected patients resulted in 100% survival at 75±30 months in a single-center cohort, with only 10% requiring late reimplantation.
Why the study?
Is it safe to permanently explant or discontinue ICD therapy without replacement in selected patients who have not received appropriate therapy?
Observational (n=10)
No
Is it safe to permanently explant or discontinue ICD therapy without replacement in selected patients who have not received appropriate therapy?
In selected patients who have not received appropriate ICD therapy for a long period, device therapy may be discontinued with some degree of safety when clinical circumstances justify.
Answers are grounded in this paper and cite their sources.
Supports selective permanent ICD explantation in low-risk patients; leaves open need for prospective trials before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Geist et al. (2000) conducted an observational in Implantable Cardioverter Defibrillator (ICD) explantation (n=10). Permanent explantation of ICD without replacement was evaluated on Long-term survival and need for reimplantation. Permanent explantation of ICDs without replacement in selected patients resulted in 100% survival at 75±30 months in a single-center cohort, with only 10% requiring late reimplantation.
Synapse has enriched 10 related papers. Consider them for comparative context: